Production (Stage)
D
Telomir Pharmaceuticals, Inc. TELO
$2.10 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 212.64% 322.64% 448.69% 336.63% 5,628.50%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 133.92% 212.08% 212.65% 106.23% 322.05%
Operating Income -133.92% -212.08% -212.65% -106.23% -322.05%
Income Before Tax 33.57% -26.94% -444.02% -580.57% -1,379.55%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 33.57% -26.94% -444.02% -580.57% -1,379.55%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 33.57% -26.94% -444.02% -580.57% -1,379.55%
EBIT -133.92% -212.08% -212.65% -106.23% -322.05%
EBITDA -- -- -- -- --
EPS Basic 38.81% -18.96% -424.01% -629.66% -1,805.52%
Normalized Basic EPS -2.13% -178.51% -247.96% -334.48% -1,048.89%
EPS Diluted 38.81% -18.96% -424.01% -629.66% -1,805.52%
Normalized Diluted EPS -2.13% -178.51% -247.96% -334.48% -1,048.89%
Average Basic Shares Outstanding 8.79% 7.82% 5.72% 38.05% 103.01%
Average Diluted Shares Outstanding 8.79% 7.82% 5.72% 38.05% 103.01%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --